ArticleStroke research and treatment2021

The Study of Cost-Effectiveness of Rivaroxaban versus Warfarin in Patients with Atrial Fibrillation Who Developed Ischemic Stroke.

Neda Jaberi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.